Relevant, timely precision oncology treatment options drive real world impact. N-of-One is now part of the QIAGEN family
N-of-One, Inc. is a leading biotechnology research company dedicated to providing clinicians with the most relevant and accurate interpretation of molecular test results. Part of the QIAGEN family, N-of-One focuses on delivering high-quality clinical insights that significantly reduce the time required to develop therapeutic strategy options for each patient case. N-of-One's expertise supports clinicians in making informed therapeutic decisions, driving real-world impact in precision oncology treatment.
Located at 430 Bedford St, Suite 390, Lexington, MA 02420, US, N-of-One is committed to excellence in molecular decision support. By focusing solely on clinical interpretation, N-of-One ensures that healthcare professionals have the information they need to provide the best possible care.
N-of-One, Inc. continually strives to enhance its services and expand its reach within the biotechnology sector. The company is dedicated to advancing precision oncology and improving patient outcomes. We invite the management team at N-of-One to create a customized and exclusive company showcase and product listing on our platform to further highlight your innovative work.
Other organizations in the same industry
This company is also known as